|
1
|
Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia.
|
Lab Invest
|
1992
|
1.57
|
|
2
|
Trace elements and urinary stone formation: new aspects of the pathological mechanism of urinary stone formation.
|
J Urol
|
1991
|
0.77
|
|
3
|
Impact of allopurinol treatment on the prevention of hyperuricosuric calcium oxalate lithiasis.
|
Eur Urol
|
1988
|
0.77
|
|
4
|
Results after organ-preserving surgery for renal cell carcinoma. An Austrian multicenter study.
|
Eur Urol
|
1990
|
0.76
|
|
5
|
Idiopathic uric acid lithiasis: epidemiologic and metabolic aspects.
|
J Urol
|
1982
|
0.75
|
|
6
|
[Effect of nutrition on the pathogenesis and metaphylaxis of urinary calculi].
|
Wien Klin Wochenschr
|
1984
|
0.75
|
|
7
|
Calcitonin- and katacalcin-like immunoreactivity in human seminal plasma.
|
Exp Clin Endocrinol
|
1986
|
0.75
|
|
8
|
[Therapeutic procedure in kidney tumors of uncertain importance].
|
Helv Chir Acta
|
1985
|
0.75
|
|
9
|
[The social infrastructure of patients with urinary calculi (author's transl)].
|
Wien Klin Wochenschr
|
1981
|
0.75
|
|
10
|
[The role of urinary excretion of magnesium in patients with urolithiasis with special respect to recurrence rate of stone formation (author's transl)].
|
Urologe A
|
1978
|
0.75
|
|
11
|
Oral purine loading for evaluation of uric acid excretion in patients with urinary calculi.
|
Invest Urol
|
1980
|
0.75
|
|
12
|
Colorectal cancer involving the urinary tract.
|
Eur Urol
|
1992
|
0.75
|
|
13
|
Experiences with continuous intraarterial administration of recombinant interferon alpha-2C (rIFN-alpha 2) for treatment of patients with advanced transitional cell bladder cancer.
|
J Biol Regul Homeost Agents
|
1988
|
0.75
|
|
14
|
[Does thermotherapy of prostatic hypertrophy interfere with pacemaker function? - First results of a pilot-study].
|
Herzschrittmacherther Elektrophysiol
|
1997
|
0.75
|
|
15
|
Calcitonin load in absorptive hypercalciuria type I.
|
Eur Urol
|
1979
|
0.75
|
|
16
|
Cardial decompensation caused by hypertension and polyglobulia associated with multiple renal oncocytomas.
|
Clin Nephrol
|
1985
|
0.75
|
|
17
|
[The evaluation of patients with urinary calculi discloses disturbances of metabolism in 75% of all cases (author's transl)].
|
Wien Klin Wochenschr
|
1979
|
0.75
|
|
18
|
[Therapy of radiation injuries of the bladder with orgotein (Peroxinom)].
|
Z Urol Nephrol
|
1988
|
0.75
|
|
19
|
[The significance of citrate excretion and calcium/citrate quotients in urine in patients with calcium calculi].
|
Z Urol Nephrol
|
1990
|
0.75
|
|
20
|
[Technics for parenchyma-conserving nephrolithotomy].
|
Urologe A
|
1984
|
0.75
|
|
21
|
[The mechanism of contrast filling of the liver following lymphography (author's transl)].
|
Rofo
|
1976
|
0.75
|
|
22
|
Methylene blue to stain the bladder mucosa and monitor the course of bladder tumors.
|
Eur Urol
|
1985
|
0.75
|
|
23
|
Nutritional risk factors in urinary stone disease.
|
J Urol
|
1981
|
0.75
|
|
24
|
Effects of external renal hypothermia on postischemic hemodynamics.
|
Urol Int
|
1983
|
0.75
|
|
25
|
[The conservative treatment of phosphate calculi by citrate buffer (author's transl)].
|
Wien Klin Wochenschr
|
1975
|
0.75
|
|
26
|
[The value attached to clinical laboratory findings in urolithiasis (author's transl)].
|
Wien Klin Wochenschr
|
1974
|
0.75
|
|
27
|
[Metabolic disorders in patients with urolithiasis].
|
Z Urol Nephrol
|
1976
|
0.75
|
|
28
|
[Excretion of calcium and uric acid in patients with urinary calculi].
|
Z Urol Nephrol
|
1976
|
0.75
|
|
29
|
[Open questions on the prevention of urinary calculi recurrence].
|
Z Urol Nephrol
|
1981
|
0.75
|
|
30
|
[Guidelines for prevention of recurrent urolithiasis (author's transl)].
|
Wien Klin Wochenschr
|
1981
|
0.75
|
|
31
|
Normocalcemic hyperparathyroidism.
|
Eur Urol
|
1981
|
0.75
|
|
32
|
[Urological problems in the treatment of recurrent colorectal carcinoma].
|
Wien Klin Wochenschr
|
1983
|
0.75
|
|
33
|
[Clinical aspects of cystinuria and its treatment by thiola (author's transl)].
|
Wien Klin Wochenschr
|
1976
|
0.75
|
|
34
|
[Oral purine loading in the routine diagnosis of patients with urinary calculi].
|
Helv Chir Acta
|
1981
|
0.75
|